HCV Tier 1 – The Approach to the Patient with HCV Infection (Monograph)
Learning Objectives
- Provide optimal quality of care based on established quality indicators for HCV patients.
- Implement HCV treatment to the fullest extent, ensuring all gaps in treatment are adequately addressed.
- Describe DAA drug therapies so that they may be administered and monitored in HCV patients, in accordance with practice guidelines.
- Implement HCV treatment to the fullest extent, ensuring all gaps in treatment are adequately addressed.
- List three side effects of DAA agents.
- Identify the timeframe for each side effect that may occur.
Available Credit
- 0.50 AMA PRA Category 1 Credit(s)™
- 0.50 Attendance